Vincerx Pharma, Inc. (VINC) Financials

VINC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 26.3 million 10.5 million
2023-06-30 35.3 million 11.1 million
2023-03-31 47.4 million 13.0 million
2022-12-31 59.3 million 11.6 million

VINC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.6 million 1.3 million
2023-06-30 -12.7 million 694000
2023-03-31 -13.1 million 1.1 million
2022-12-31 -13.8 million 1.5 million

VINC Net Income

No data available :(

VINC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 20.8 million - 2.8 million
2023-06-30 27.4 million - 3.0 million
2023-03-31 39.8 million - 3.3 million
2022-12-31 52.5 million - 3.4 million

VINC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 21.3 million
2023-06-30 21.3 million
2023-03-31 21.2 million
2022-12-31 21.1 million

VINC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 6.8 million 3.5 million -
2023-06-30 - 7.9 million 3.8 million -
2023-03-31 - 10.6 million 4.5 million -
2022-12-31 - 11.4 million 4.1 million -

VINC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 254000
2023-06-30 - 249000
2023-03-31 - 154000
2022-12-31 - 241000

VINC

Price: $0.89

52 week price:
0.61
9.37

Earnings Per Share: -1.89 USD

P/E Ratio: -0.68

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 181372

Market Capitalization: 21.0 million

Links: